CENCORA INC (ABG.DE) Stock Fundamental Analysis
Europe - FRA:ABG - US03073E1055 - Common Stock
305.55 EUR
+16.3 (+5.64%)
ABG gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 27 industry peers in the Health Care Providers & Services industry. ABG has only an average score on both its financial health and profitability. ABG is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ABG was profitable.
In the past year ABG had a positive cash flow from operations.
Of the past 5 years ABG 4 years were profitable.
ABG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ABG has a Return On Assets of 2.57%. This is comparable to the rest of the industry: ABG outperforms 55.56% of its industry peers.
Looking at the Return On Equity, with a value of 95.81%, ABG belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Return On Invested Capital of ABG (13.52%) is better than 96.30% of its industry peers.
ABG had an Average Return On Invested Capital over the past 3 years of 16.51%. This is significantly above the industry average of 6.04%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.57% | ||
| ROE | 95.81% | ||
| ROIC | 13.52% |
ROA(3y)2.68%
ROA(5y)0.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)16.51%
ROIC(5y)15.55%
1.3 Margins
Looking at the Profit Margin, with a value of 0.60%, ABG is doing worse than 62.96% of the companies in the same industry.
In the last couple of years the Profit Margin of ABG has grown nicely.
ABG has a Operating Margin of 1.09%. This is in the lower half of the industry: ABG underperforms 77.78% of its industry peers.
In the last couple of years the Operating Margin of ABG has remained more or less at the same level.
ABG has a Gross Margin of 3.40%. This is in the lower half of the industry: ABG underperforms 77.78% of its industry peers.
ABG's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.09% | ||
| PM (TTM) | 0.6% | ||
| GM | 3.4% |
OM growth 3Y-6.12%
OM growth 5Y-0.1%
PM growth 3Y-10.65%
PM growth 5Y1.52%
GM growth 3Y1.72%
GM growth 5Y3.69%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ABG is creating value.
ABG has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ABG has less shares outstanding
ABG has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 5.05 indicates that ABG is not in any danger for bankruptcy at the moment.
The Altman-Z score of ABG (5.05) is better than 92.59% of its industry peers.
The Debt to FCF ratio of ABG is 7.22, which is on the high side as it means it would take ABG, 7.22 years of fcf income to pay off all of its debts.
ABG has a Debt to FCF ratio of 7.22. This is in the better half of the industry: ABG outperforms 66.67% of its industry peers.
ABG has a Debt/Equity ratio of 4.06. This is a high value indicating a heavy dependency on external financing.
ABG's Debt to Equity ratio of 4.06 is on the low side compared to the rest of the industry. ABG is outperformed by 81.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.06 | ||
| Debt/FCF | 7.22 | ||
| Altman-Z | 5.05 |
ROIC/WACC1.5
WACC9.04%
2.3 Liquidity
ABG has a Current Ratio of 0.90. This is a bad value and indicates that ABG is not financially healthy enough and could expect problems in meeting its short term obligations.
ABG has a Current ratio of 0.90. This is in the lower half of the industry: ABG underperforms 62.96% of its industry peers.
A Quick Ratio of 0.53 indicates that ABG may have some problems paying its short term obligations.
With a Quick ratio value of 0.53, ABG is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.9 | ||
| Quick Ratio | 0.53 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.64% over the past year.
The Earnings Per Share has been growing by 14.21% on average over the past years. This is quite good.
ABG shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.56%.
The Revenue has been growing by 10.36% on average over the past years. This is quite good.
EPS 1Y (TTM)16.64%
EPS 3Y14.11%
EPS 5Y14.21%
EPS Q2Q%19.76%
Revenue 1Y (TTM)11.56%
Revenue growth 3Y11.16%
Revenue growth 5Y10.36%
Sales Q2Q%8.65%
3.2 Future
ABG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.42% yearly.
ABG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.38% yearly.
EPS Next Y16.99%
EPS Next 2Y13.28%
EPS Next 3Y12.26%
EPS Next 5Y11.42%
Revenue Next Year9.7%
Revenue Next 2Y8.11%
Revenue Next 3Y7.61%
Revenue Next 5Y7.38%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 22.75, which indicates a rather expensive current valuation of ABG.
Based on the Price/Earnings ratio, ABG is valued a bit more expensive than the industry average as 62.96% of the companies are valued more cheaply.
ABG's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.83.
With a Price/Forward Earnings ratio of 19.96, ABG is valued on the expensive side.
Based on the Price/Forward Earnings ratio, ABG is valued a bit more expensive than the industry average as 70.37% of the companies are valued more cheaply.
ABG's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 32.68.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.75 | ||
| Fwd PE | 19.96 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ABG indicates a slightly more expensive valuation: ABG is more expensive than 77.78% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ABG is valued a bit more expensive than 74.07% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 59.85 | ||
| EV/EBITDA | 16.34 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ABG has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ABG's earnings are expected to grow with 12.26% in the coming years.
PEG (NY)1.34
PEG (5Y)1.6
EPS Next 2Y13.28%
EPS Next 3Y12.26%
5. Dividend
5.1 Amount
With a yearly dividend of 0.64%, ABG is not a good candidate for dividend investing.
ABG's Dividend Yield is comparable with the industry average which is at 2.55.
With a Dividend Yield of 0.64, ABG pays less dividend than the S&P500 average, which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.64% |
5.2 History
The dividend of ABG has a limited annual growth rate of 5.42%.
Dividend Growth(5Y)5.42%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
ABG pays out 22.69% of its income as dividend. This is a sustainable payout ratio.
The dividend of ABG is growing, but earnings are growing more, so the dividend growth is sustainable.
DP22.69%
EPS Next 2Y13.28%
EPS Next 3Y12.26%
FRA:ABG (11/6/2025, 7:00:00 PM)
305.55
+16.3 (+5.64%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners93.38%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap59.24B
Revenue(TTM)316.65B
Net Income(TTM)1.90B
Analysts79.09
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.64% |
Yearly Dividend1.82
Dividend Growth(5Y)5.42%
DP22.69%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.88%
Min EPS beat(2)3.15%
Max EPS beat(2)6.6%
EPS beat(4)4
Avg EPS beat(4)4.45%
Min EPS beat(4)2.68%
Max EPS beat(4)6.6%
EPS beat(8)8
Avg EPS beat(8)4.51%
EPS beat(12)12
Avg EPS beat(12)3.81%
EPS beat(16)15
Avg EPS beat(16)3.45%
Revenue beat(2)0
Avg Revenue beat(2)-0.82%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.35%
Revenue beat(4)2
Avg Revenue beat(4)0.52%
Min Revenue beat(4)-1.29%
Max Revenue beat(4)2.93%
Revenue beat(8)5
Avg Revenue beat(8)0.6%
Revenue beat(12)8
Avg Revenue beat(12)0.97%
Revenue beat(16)10
Avg Revenue beat(16)0.83%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0.07%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.01%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.75 | ||
| Fwd PE | 19.96 | ||
| P/S | 0.22 | ||
| P/FCF | 59.85 | ||
| P/OCF | 39.22 | ||
| P/B | 34.5 | ||
| P/tB | N/A | ||
| EV/EBITDA | 16.34 |
EPS(TTM)13.43
EY4.4%
EPS(NY)15.31
Fwd EY5.01%
FCF(TTM)5.11
FCFY1.67%
OCF(TTM)7.79
OCFY2.55%
SpS1416.15
BVpS8.86
TBVpS-72.79
PEG (NY)1.34
PEG (5Y)1.6
Graham Number51.73
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.57% | ||
| ROE | 95.81% | ||
| ROCE | 17.33% | ||
| ROIC | 13.52% | ||
| ROICexc | 15.22% | ||
| ROICexgc | N/A | ||
| OM | 1.09% | ||
| PM (TTM) | 0.6% | ||
| GM | 3.4% | ||
| FCFM | 0.36% |
ROA(3y)2.68%
ROA(5y)0.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)16.51%
ROIC(5y)15.55%
ROICexc(3y)21.56%
ROICexc(5y)21.55%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)21.17%
ROCE(5y)19.93%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y15.26%
ROICexc growth 5Y0.87%
OM growth 3Y-6.12%
OM growth 5Y-0.1%
PM growth 3Y-10.65%
PM growth 5Y1.52%
GM growth 3Y1.72%
GM growth 5Y3.69%
F-Score6
Asset Turnover4.28
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 4.06 | ||
| Debt/FCF | 7.22 | ||
| Debt/EBITDA | 1.77 | ||
| Cap/Depr | 55.39% | ||
| Cap/Sales | 0.19% | ||
| Interest Coverage | 10.99 | ||
| Cash Conversion | 38.29% | ||
| Profit Quality | 60.17% | ||
| Current Ratio | 0.9 | ||
| Quick Ratio | 0.53 | ||
| Altman-Z | 5.05 |
F-Score6
WACC9.04%
ROIC/WACC1.5
Cap/Depr(3y)53.4%
Cap/Depr(5y)67.19%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.19%
Profit Quality(3y)175.45%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.64%
EPS 3Y14.11%
EPS 5Y14.21%
EPS Q2Q%19.76%
EPS Next Y16.99%
EPS Next 2Y13.28%
EPS Next 3Y12.26%
EPS Next 5Y11.42%
Revenue 1Y (TTM)11.56%
Revenue growth 3Y11.16%
Revenue growth 5Y10.36%
Sales Q2Q%8.65%
Revenue Next Year9.7%
Revenue Next 2Y8.11%
Revenue Next 3Y7.61%
Revenue Next 5Y7.38%
EBIT growth 1Y19.18%
EBIT growth 3Y4.36%
EBIT growth 5Y10.24%
EBIT Next Year29.12%
EBIT Next 3Y14.27%
EBIT Next 5YN/A
FCF growth 1Y-59.12%
FCF growth 3Y10.42%
FCF growth 5Y8.07%
OCF growth 1Y-46.38%
OCF growth 3Y9.35%
OCF growth 5Y8.25%
CENCORA INC / ABG.DE FAQ
What is the fundamental rating for ABG stock?
ChartMill assigns a fundamental rating of 5 / 10 to ABG.DE.
Can you provide the valuation status for CENCORA INC?
ChartMill assigns a valuation rating of 2 / 10 to CENCORA INC (ABG.DE). This can be considered as Overvalued.
What is the profitability of ABG stock?
CENCORA INC (ABG.DE) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for ABG stock?
The Price/Earnings (PE) ratio for CENCORA INC (ABG.DE) is 22.75 and the Price/Book (PB) ratio is 34.5.
How financially healthy is CENCORA INC?
The financial health rating of CENCORA INC (ABG.DE) is 4 / 10.